AGL 40.23 Increased By ▲ 0.20 (0.5%)
AIRLINK 127.90 Increased By ▲ 0.20 (0.16%)
BOP 6.72 Increased By ▲ 0.11 (1.66%)
CNERGY 4.50 Decreased By ▼ -0.10 (-2.17%)
DCL 8.90 Increased By ▲ 0.11 (1.25%)
DFML 41.48 Decreased By ▼ -0.10 (-0.24%)
DGKC 86.55 Increased By ▲ 0.76 (0.89%)
FCCL 32.60 Increased By ▲ 0.11 (0.34%)
FFBL 65.00 Increased By ▲ 0.97 (1.51%)
FFL 11.61 Increased By ▲ 1.06 (10.05%)
HUBC 113.50 Increased By ▲ 2.73 (2.46%)
HUMNL 14.80 Decreased By ▼ -0.27 (-1.79%)
KEL 5.04 Increased By ▲ 0.16 (3.28%)
KOSM 7.33 Decreased By ▼ -0.12 (-1.61%)
MLCF 40.53 Increased By ▲ 0.01 (0.02%)
NBP 61.48 Increased By ▲ 0.43 (0.7%)
OGDC 196.21 Increased By ▲ 1.34 (0.69%)
PAEL 27.54 Increased By ▲ 0.03 (0.11%)
PIBTL 7.37 Decreased By ▼ -0.44 (-5.63%)
PPL 154.70 Increased By ▲ 2.17 (1.42%)
PRL 26.36 Decreased By ▼ -0.22 (-0.83%)
PTC 16.33 Increased By ▲ 0.07 (0.43%)
SEARL 85.85 Increased By ▲ 1.71 (2.03%)
TELE 7.78 Decreased By ▼ -0.18 (-2.26%)
TOMCL 36.40 Decreased By ▼ -0.20 (-0.55%)
TPLP 8.90 Increased By ▲ 0.24 (2.77%)
TREET 16.69 Decreased By ▼ -0.97 (-5.49%)
TRG 62.73 Increased By ▲ 4.11 (7.01%)
UNITY 28.60 Increased By ▲ 1.74 (6.48%)
WTL 1.34 Decreased By ▼ -0.04 (-2.9%)
BR100 10,145 Increased By 144.6 (1.45%)
BR30 31,457 Increased By 455 (1.47%)
KSE100 95,185 Increased By 993.2 (1.05%)
KSE30 29,559 Increased By 357.9 (1.23%)

BEIJING: China on Friday said it would for the first time allow the general public to use rapid COVID-19 antigen tests that do not need medical workers to take samples as it steps up efforts to ensure infections are identified at an early stage.

In China’s latest and previous local outbreaks, many Chinese cities had tested tens of thousands of people after a handful of cases emerged.

That strategy could become more challenging as the daily rise in domestically-transmitted cases reached a two-year high for the country this week, as the highly contagious Omicron variant spreads and many carriers are asymptomatic.

WHO announces 2nd hub for training countries to make COVID vaccines

Antigen tests that can be used by individuals have helped to relieve testing bottlenecks in countries such Singapore and South Korea, while China, where case numbers remained relatively low, relied on nucleic acid tests that require medical professionals to take samples.

People under quarantine or lockdown will be able to use self-use antigen tests under supervision of the authorities, while other residents who need such tests will be able to buy kits in stores or online, the National Health Commission said on its website.

China has boosted its nucleic acid testing capacity in the last two years and those tests will continue to be used for diagnosis of those who test positive for COVID-19. Those who tested positive using antigen test and those negative but showing suspicious symptoms should still undergo nucleic acid tests.

Antigen test requirement scrapped for travellers to Dubai, Sharjah from Pakistan

Chinese authorities said in February that rapid antigen tests are allowed for staffers working on ships that arrive from abroad when nucleic acid tests are unavailable, without specifying whether those antigen tests could be used without medical workers taking samples or not.

Comments

Comments are closed.